Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Y Yu

Showing results (81-90 of 234) with videos related to

Pageof 24
Sort By:
European Urology Oncology|May 24, 2025
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair DeficiencyRuben Raychaudhuri, Heather H Cheng, Roman Gulati, et al.
Clinical Genitourinary Cancer|February 25, 2014
Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancerAndrew C James, Franklin C Lee, Jason P Izard, et al.
JAMA Oncology|November 5, 2020
Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing InterferenceKendal Jensen, Eric Q Konnick, Michael T Schweizer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2024
SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving <sup>177</sup>Lu-PSMA-617Ridvan Arda Demirci, Roman Gulati, Jessica E Hawley, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 18, 2016
The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With ChemotherapyJorge D Ramos, Martin F Casey, Aristotelis Bamias, et al.
Plos One|June 2, 2018
A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
Plos One|August 16, 2018
Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2025
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO GuidelineEvan Y Yu, R Bryan Rumble, Neeraj Agarwal, et al.
Urology|December 29, 2020
Social and Clinical Correlates of Neoadjuvant Chemotherapy in Medicare Beneficiaries With Muscle Invasive Bladder Cancer From 2004-2015Yaw A Nyame, Sarah K Holt, Leonidas N Diamontopoulos, et al.
Oncotarget|October 21, 2016
Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostateMichael T Schweizer, Heather H Cheng, Maria S Tretiakova, et al.
Pageof 24

Showing results (81-90 of 234) with videos related to

Sort By:
Pageof 24
European Urology Oncology|May 24, 2025
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair DeficiencyRuben Raychaudhuri, Heather H Cheng, Roman Gulati, et al.
Clinical Genitourinary Cancer|February 25, 2014
Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancerAndrew C James, Franklin C Lee, Jason P Izard, et al.
JAMA Oncology|November 5, 2020
Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing InterferenceKendal Jensen, Eric Q Konnick, Michael T Schweizer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2024
SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving <sup>177</sup>Lu-PSMA-617Ridvan Arda Demirci, Roman Gulati, Jessica E Hawley, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 18, 2016
The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With ChemotherapyJorge D Ramos, Martin F Casey, Aristotelis Bamias, et al.
Plos One|June 2, 2018
A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
Plos One|August 16, 2018
Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2025
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO GuidelineEvan Y Yu, R Bryan Rumble, Neeraj Agarwal, et al.
Urology|December 29, 2020
Social and Clinical Correlates of Neoadjuvant Chemotherapy in Medicare Beneficiaries With Muscle Invasive Bladder Cancer From 2004-2015Yaw A Nyame, Sarah K Holt, Leonidas N Diamontopoulos, et al.
Oncotarget|October 21, 2016
Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostateMichael T Schweizer, Heather H Cheng, Maria S Tretiakova, et al.
Pageof 24